Pharmacokinetic Interaction Between Dapsone and Rifampicin in Leprosy Patients
D. R. Krishna, A. V. N. Appa Rao, T. V. Ramanakar, M. C. Prabhakar
Abstract
D. R. Krishna, A. V. N. Appa Rao, T. V. Ramanakar, M. C. Prabhakar
Abstract
Different pharmacokinetic parameters of dapsone and rifampicin following P. O. administration of dapsone 100 mg. alone, rifampicin 600 mg. alone and dapsone 100 mg. plus rifampicin 600 mg. in 7 cases of untreated patients of leprosy were investigated. The blood levels, half-life and AUC0-8 hrs. of dapsone were significantly reduced with simultaneous increase in plasma clearance when it was administered along with rifampicin. The pharmacokinetic behaviour of rifampicin was, however, not significantly affected in the presence of dapsone.
OpenAlex reports 6 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Different pharmacokinetic parameters of dapsone and rifampicin following P. O. administration of dapsone 100 mg. alone, rifampicin 600 mg. alone and dapsone 100 mg. plus rifampicin 600 mg. in 7 cases of untreated patients of leprosy were investigated. The blood levels, half-life and AUC0-8 hrs. of dapsone were significantly reduced with simultaneous increase in plasma clearance when it was administered along with rifampicin. The pharmacokinetic behaviour of rifampicin was, however, not significantly affected in the presence of dapsone.
Key concepts: Dapsone, Rifampicin, Pharmacokinetics, Leprosy, Pharmacology, Medicine, Immunology, Tuberculosis